What is the appropriate workup for benign prostatic hyperplasia?

Workup for Benign Prostatic Hyperplasia

The initial workup for BPH requires a focused history with validated symptom scoring, digital rectal examination, urinalysis, serum PSA measurement, and post-void residual urine assessment 1.

Mandatory Components

History and Symptom Assessment

• Use the International Prostate Symptom Score (IPSS) or American Urological Association Symptom Index to objectively quantify symptom severity and impact on quality of life 1
• Document onset, duration, and progression of both storage symptoms (urgency, frequency, nocturia) and voiding symptoms (hesitancy, weak stream, incomplete emptying)
• Review medications that may worsen LUTS (anticholinergics, decongestants, diuretics)
• Assess for complications: hematuria, recurrent UTIs, acute urinary retention, or bladder stones

Physical Examination

• Digital rectal examination (DRE) is mandatory to assess prostate size, consistency, and detect nodules or induration that would require cancer evaluation 1, 2
• Check for bladder distention via suprapubic palpation
• Perform focused neurologic examination to exclude neurogenic causes

Laboratory Testing

• Urinalysis is mandatory to identify infection, hematuria (requiring bladder cancer workup), or glucosuria 1, 3
• Serum PSA measurement is recommended to help estimate prostate size and assess prostate cancer risk 1, 3
• Serum creatinine or renal ultrasound is recommended to evaluate for hydronephrosis or renal impairment from chronic obstruction 1, 2

Objective Measurements

• Uroflowmetry is recommended to objectively measure maximum flow rate (Qmax <10-12 mL/sec suggests obstruction) 1, 2
• Post-void residual (PVR) urine volume is recommended via bladder scan or catheterization; elevated PVR (>200-300 mL) indicates incomplete emptying and higher risk of complications 1, 2

Optional/Situational Tests

The following are not routinely required but may be indicated in specific circumstances 1, 2:

• Prostate ultrasound (transrectal or transabdominal) for precise volume measurement when considering 5-alpha reductase inhibitor therapy (most beneficial if prostate >30-40 grams) 1
• Urodynamic studies reserved for patients with:
  • Unclear diagnosis
  • Predominant storage symptoms suggesting detrusor overactivity
  • Previous failed surgical intervention
  • Neurologic disease
  • Young age (<50 years) with severe symptoms
• Cystoscopy indicated for:
  • Persistent hematuria requiring evaluation
  • History of urethral stricture
  • Prior urethral/bladder surgery
  • Consideration of surgical intervention
• Upper tract imaging (CT or ultrasound) if elevated creatinine, hydronephrosis suspected, or history of stones

Critical Decision Points

When to Refer to Urology

Immediate or urgent referral is warranted for 1, 3:

• Suspicious DRE findings (nodules, induration, asymmetry)
• Persistent hematuria
• Elevated PSA requiring further evaluation
• Acute urinary retention
• Recurrent UTIs
• Bladder stones
• Renal insufficiency from obstruction
• Failed medical management
• Patient preference for surgical intervention

Common Pitfalls to Avoid

• Do not assume all LUTS in older men are from BPH - consider bladder cancer, neurogenic bladder, urethral stricture, and bladder stones
• Do not skip PSA testing due to concerns about overdiagnosis; it provides valuable information about prostate size and helps risk-stratify for cancer 3
• Do not order extensive imaging or urodynamics routinely - these are optional tests that add cost without improving outcomes in uncomplicated cases 1, 2
• Do not forget to assess for medication-induced LUTS - many common drugs worsen urinary symptoms

Severity Stratification

Based on IPSS/AUA-SI scores 1, 3:

• Mild symptoms (0-7): Watchful waiting with annual reassessment
• Moderate symptoms (8-19): Consider medical therapy if bothersome to patient
• Severe symptoms (20-35): Medical therapy or surgical referral depending on patient preference and presence of complications

The workup should be streamlined and cost-effective, focusing on mandatory tests that identify complications requiring urgent intervention while avoiding unnecessary testing in straightforward cases. The 2021 AUA guidelines emphasize that this algorithmic approach balances thoroughness with practicality for both primary care and urology providers 1.